Institute for Research in Operative Medicine (IFOM), Witten / Herdecke University, Cologne, Germany
Institute for Research in Operative Medicine (IFOM), Witten / Herdecke University, Cologne, Germany.
BMJ Open. 2022 Mar 16;12(3):e059040. doi: 10.1136/bmjopen-2021-059040.
The German Guideline Program in Oncology (GGPO) has published patient versions of clinical practice guidelines for more than 10 years. However, a systematic evaluation of these is lacking. The project aims to investigate the role and applicability of patient versions by considering the perspectives of experts, patients and healthcare providers to derive recommendations for the development, dissemination and implementation of patient versions in Germany.
The project comprises two main modules. In module 1, we will first obtain information on methods and approaches for the development, dissemination and implementation of patient versions by conducting systematic searches in Medline and screening the websites of guideline organisations. We will include any articles, such as methodological or empirical reports, published in German or English since 2000, that address methodological aspects related to patient versions. Further, we will conduct 20 interviews with experts from international and German organisations who are involved in the development of patient versions. In module 2, we will first conduct interviews to explore patients and healthcare providers' perceptions of patient versions of the GGPO. For the group of patients and the group of healthcare providers, we aim to conduct 25 interviews each. Second, we will conduct focus groups, separately for breast, prostate and colon cancer. The recruitment of participants for the interviews and focus groups will primarily be done through a previous survey about patient versions in oncology. The results will be used to derive recommendations for enhancing the development, dissemination and implementation of patient versions by involving the relevant stakeholder groups.
Ethical approval for the qualitative parts of the project was given by the Ethics Committee of Witten/Herdecke University (number 160/2021). Participants will be required to provide informed consent. The project findings will be published in peer-reviewed journals and presented at scientific conferences.
德国肿瘤临床实践指南计划（GGPO）已经出版了超过 10 年的患者版临床实践指南。然而，这些指南的系统评估仍然缺乏。该项目旨在通过考虑专家、患者和医疗保健提供者的观点，研究患者版的作用和适用性，为德国患者版的开发、传播和实施提供建议。
该项目包括两个主要模块。在模块 1 中，我们将首先通过在 Medline 中进行系统搜索并筛选指南组织的网站，获取有关患者版的开发、传播和实施的方法和方法的信息。我们将包括自 2000 年以来以英文或德文发表的任何与患者版相关的方法学或经验报告，如方法学或经验报告。此外，我们将对来自国际和德国组织的 20 名参与患者版开发的专家进行访谈。在模块 2 中，我们将首先进行访谈，以探讨患者和医疗保健提供者对 GGPO 患者版的看法。对于患者组和医疗保健提供者组，我们的目标是每组进行 25 次访谈。其次，我们将分别为乳腺癌、前列腺癌和结肠癌患者举办焦点小组。访谈和焦点小组参与者的招募主要通过之前关于肿瘤学患者版的调查进行。结果将用于通过涉及相关利益相关者群体来增强患者版的开发、传播和实施。
该项目的定性部分的伦理批准由 Witten/Herdecke 大学伦理委员会（编号 160/2021）授予。参与者将被要求提供知情同意。项目研究结果将发表在同行评议期刊上，并在科学会议上展示。
